Corebridge Financial’s Keros Therapeutics KROS Stock Holding History

Corebridge Financial’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$165K	Buy
2024 Q4	$241K	Sell
2024 Q3	$915K	Sell
2024 Q2	$724K	Buy